We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

490 hedge funds and large institutions have $11.5B invested in Bio-Rad Laboratories Class A in 2020 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 177 increasing their positions, 176 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more funds holding in top 10

Funds holding in top 10: 5 → 7 (+2)

33% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 57

16% more capital invested

Capital invested by funds: $9.85B → $11.5B (+$1.61B)

3% more funds holding

Funds holding: 478 → 490 (+12)

1.14% more ownership

Funds ownership: 78.38% → 79.52% (+1.1%)

1% more repeat investments, than reductions

Existing positions increased: 177 | Existing positions reduced: 176

8% less call options, than puts

Call options by funds: $14.7M | Put options by funds: $16M

Holders
490
Holders Change
+12
Holders Change %
+2.51%
% of All Funds
8.67%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
76
Increased
177
Reduced
176
Closed
57
Calls
$14.7M
Puts
$16M
Net Calls
-$1.25M
Net Calls Change
+$4.17M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$164M
2
BlackRock
BlackRock
New York
+$154M
3
HM
HealthCor Management
New York
+$79.8M
4
California Public Employees Retirement System
California Public Employees Retirement System
California
+$72.4M
5
UBS AM
UBS AM
Illinois
+$66.9M

Top Sellers

1
GQG Partners
GQG Partners
Florida
-$183M
2
American Century Companies
American Century Companies
Missouri
-$102M
3
ACM
Atlanta Capital Management
Georgia
-$89.1M
4
AQR Capital Management
AQR Capital Management
Connecticut
-$48.1M
5
Wells Fargo
Wells Fargo
California
-$42.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCV
301
Banque Cantonale Vaudoise
Switzerland
$641K -$968K -1,700 -61%
SDIC
302
South Dakota Investment Council
South Dakota
$630K -$342K -600 -36%
AP
303
Advisor Partners
California
$628K +$38.7K +68 +7%
VanEck Associates
304
VanEck Associates
New York
$626K +$408K +716 +200%
NA
305
NewEdge Advisors
Louisiana
$614K +$95.1K +167 +19%
QI
306
Qtron Investments
Massachusetts
$607K +$96.8K +170 +19%
BDF
307
Balasa Dinverno & Foltz
$599K +$90K +158 +18%
SIA
308
Strategic Investment Advisors
Michigan
$586K +$573K +1,006 New
ECM
309
Everence Capital Management
Indiana
$583K +$285K +500 +100%
SI
310
Symmetry Investments
Jersey
$583K +$570K +1,000 New
HIIFS
311
Harel Insurance Investments & Financial Services
Israel
$570K – – –
EOJOAM
312
E. Ohman J:or Asset Management
Sweden
$556K – – –
Macquarie Group
313
Macquarie Group
Australia
$543K -$1.63M -2,859 -75%
RP
314
Rowlandmiller & Partners
Georgia
$542K +$529K +929 New
Janney Montgomery Scott
315
Janney Montgomery Scott
Pennsylvania
$539K +$276K +484 +110%
BRWA
316
B. Riley Wealth Advisors
Florida
$538K +$25.1K +44 +5%
HAG
317
HighPoint Advisor Group
Illinois
$531K +$50.7K +89 +12%
National Pension Service
318
National Pension Service
South Korea
$527K +$167K +294 +48%
Los Angeles Capital Management
319
Los Angeles Capital Management
California
$501K -$22.8K -40 -4%
RA
320
RFG Advisory
Alabama
$498K -$36.4K -64 -7%
ECM
321
Evergreen Capital Management
Washington
$487K +$30.2K +53 +7%
CI
322
Cigna Investments
Connecticut
$472K -$7.97K -14 -2%
Nomura Holdings
323
Nomura Holdings
Japan
$466K +$154K +271 +51%
CTC
324
Central Trust Company
Missouri
$464K -$23.4K -41 -5%
IRF
325
IBM Retirement Fund
New York
$455K +$54.1K +95 +14%
11 12
13
14 15

BIO Hedge Fund Activity: Q4 2020 in Review

490 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q4 2020, worth a combined $11.5B — up 16% from $9.85B a quarter earlier.

Buyers outnumbered sellers: 76 funds opened new BIO positions and 57 closed out — a net gain of 19 holders — while 177 added to existing stakes and 176 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $164M. The largest seller was GQG Partners, exiting entirely with an estimated $183M sold.

  • 490 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q4 2020, up from 478 in Q3 2020.
  • Funds reported $11.5B of Bio-Rad Laboratories Class A stock for Q4 2020, up 16% quarter-over-quarter.
  • 76 funds opened new Bio-Rad Laboratories Class A positions in Q4 2020 and 57 closed out, a net change of +19 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q4 2020 was Fidelity Investments, an estimated $164M added.
  • The largest Bio-Rad Laboratories Class A seller in Q4 2020 was GQG Partners, an estimated $183M sold.

Based on aggregated 13F filings for Q4 2020.